Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Galsky, Matthew D ; Arija, José Ángel Arranz ; Bamias, Aristotelis ; Davis, Ian D ; De Santis, Maria ; Kikuchi, Eiji ; Garcia-del-Muro, Xavier ; De Giorgi, Ugo ; Mencinger, Marina ; Izumi, Kouji ; Panni, Stefano ; Gumus, Mahmut ; Özgüroğlu, Mustafa ; Kalebasty, Arash Rezazadeh ; Park, Se Hoon ; Alekseev, Boris ; Schutz, Fabio A ; Li, Jian-Ri ; Ye, Dingwei ; Vogelzang, Nicholas J ; Bernhard, Sandrine ; Tayama, Darren ; Mariathasan, Sanjeev ; Mecke, Almut ; Thåström, AnnChristine ; Grande, Enrique
The Lancet (British edition), 2020-05, Vol.395 (10236), p.1547-1557 [Periódico revisado por pares]England: Elsevier Ltd
Texto completo disponível